Featured Question

My patient is a 28-year-old male who was diagnosed with MS 12 years ago, and has failed on high-dose β interferons, glatiramer acetate, and natalizumab. He has baseline bradycardia (~50 beats per minute). What is the next step for this patient?

See The Answer

Get the latest
science delivered
to your inbox

Answers in CME updates are
available in YOUR specialty.

Sign-up Now!

Featured Activities

12-31-2013

NHL Cases in Point: Applying Current Evidence to Challenging Patient Scenarios

Course Director
Anas Younes, MD
Memorial Sloan-Kettering Cancer Center
New York, New York

12-31-2013

How to Overcome Common Challenges in Managing Patients With Retinal Disorders: Looking to the Latest Evidence for Answers

Course Director
Carl Regillo, MD
Thomas Jefferson University
Wills Eye Hospital
Philadelphia, Pennsylvania

12-27-2013

An Update on Clinical Trials Evaluating Chemotherapy-Free Approaches to NHL

Course Director
Anas Younes, MD
Memorial Sloan-Kettering Cancer Center
New York, New York

12-20-2013

State of the Science in Retinal Disorders: Latest Advances in the Treatment of DME, AMD, and BRVO

Course Director
Carl Regillo, MD
Thomas Jefferson University
Wills Eye Hospital
Philadelphia, Pennsylvania

12-18-2013

Q&A: Overcoming Challenges in the Treatment of Major Depressive Disorder

Course Director
Ian A. Cook, MD
David Geffen School of Medicine at UCLA
Semel Institute for Neuroscience and Human Behavior
UCLA Brain Research Institute
Los Angeles, California

12-11-2013

Refining the Management of Patients With CLL: Update on Prognostic/Predictive Factors and New Therapies

Course Director
William G. Wierda, MD, PhD
Professor, Department of Leukemia
Division of Cancer Medicine
The University of Texas MD Anderson Cancer Center
Houston, Texas

12-06-2013

Practical Guidance for Overcoming Challenging Patient-Care Issues in MS

Course Director
Daniel Ontaneda, MD, MS
Cleveland Clinic Lerner College of Medicine
Case Western Reserve University
Cleveland, Ohio

12-05-2013

Translating an Improved Understanding of Disease Biology Into New Targets and Combinations for the Treatment of Advanced Skin Cancers

Course Director
Antoni Ribas, MD, PhD
Jonsson Comprehensive Cancer Center
University of California Los Angeles
Los Angeles, California

11-27-2013

Overcoming Challenges in Managing Patients With Dermatologic Disorders: A Case-Based Discussion of Atopic Dermatitis, Acne Vulgaris, and Melanoma

Course Director
Steven R. Feldman, MD, PhD
Psoriasis Treatment Center
Wake Forest University School of Medicine
Winston-Salem, North Carolina

11-22-2013

Latest Treatment Advances in MS: Need-to-Know Science and Implications for Practice

Course Director
Daniel Ontaneda, MD, MS
Cleveland Clinic Lerner College of Medicine
Case Western Reserve University
Cleveland, Ohio